BI754111 & BI754091 BI75411 combination
Research payments
$155,016
Through program year 2023, $155,016 in research payments was reported against BI754111 & BI754091 BI75411 combination, across 25 payments.
- Paid by (largest first)
- Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharmaceuticals, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $12,636 | 3 |
| 2022 | Research | $102,814 | 7 |
| 2021 | Research | $286 | 1 |
| 2020 | Research | $14,610 | 7 |
| 2019 | Research | $24,669 | 7 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
6 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.